Elevance Health, Inc. (FRA:A58)

Elevance Health Statistics

Total Valuation

Elevance Health has a market cap or net worth of EUR 58.97 billion. The enterprise value is 77.74 billion.

Market Cap	58.97B
Enterprise Value	77.74B

Important Dates

The last earnings date was Wednesday, July 16, 2025.

Earnings Date	Jul 16, 2025
Ex-Dividend Date	Jun 10, 2025

Share Statistics

Current Share Class	225.93M
Shares Outstanding	n/a
Shares Change (YoY)	-2.43%
Shares Change (QoQ)	-0.62%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	225.42M

Valuation Ratios

The trailing PE ratio is 12.92 and the forward PE ratio is 8.63.

PE Ratio	12.92
Forward PE	8.63
PS Ratio	0.37
PB Ratio	1.58
P/TBV Ratio	17.92
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.41, with an EV/FCF ratio of 17.11.

EV / Earnings	17.03
EV / Sales	0.48
EV / EBITDA	9.41
EV / EBIT	10.43
EV / FCF	17.11

Financial Position

The company has a current ratio of 1.44, with a Debt / Equity ratio of 0.69.

Current Ratio	1.44
Quick Ratio	1.32
Debt / Equity	0.69
Debt / EBITDA	3.15
Debt / FCF	5.66
Interest Coverage	6.52

Financial Efficiency

Return on equity (ROE) is 12.42% and return on invested capital (ROIC) is 7.36%.

Return on Equity (ROE)	12.42%
Return on Assets (ROA)	4.60%
Return on Invested Capital (ROIC)	7.36%
Return on Capital Employed (ROCE)	11.06%
Revenue Per Employee	1.55M
Profits Per Employee	43,801
Employee Count	104,200
Asset Turnover	1.61
Inventory Turnover	n/a

Taxes

In the past 12 months, Elevance Health has paid 1.46 billion in taxes.

Income Tax	1.46B
Effective Tax Rate	24.32%

Stock Price Statistics

The stock price has decreased by -39.51% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-39.51%
50-Day Moving Average	326.97
200-Day Moving Average	370.02
Relative Strength Index (RSI)	38.07
Average Volume (20 Days)	7

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.43

Income Statement

In the last 12 months, Elevance Health had revenue of EUR 161.15 billion and earned 4.56 billion in profits. Earnings per share was 19.91.

Revenue	161.15B
Gross Profit	43.25B
Operating Income	7.36B
Pretax Income	6.02B
Net Income	4.56B
EBITDA	7.99B
EBIT	7.36B
Earnings Per Share (EPS)	19.91

Balance Sheet

The company has 29.63 billion in cash and 25.70 billion in debt, giving a net cash position of -18.41 billion.

Cash & Cash Equivalents	29.63B
Total Debt	25.70B
Net Cash	-18.41B
Net Cash Per Share	n/a
Equity (Book Value)	37.34B
Book Value Per Share	164.88
Working Capital	16.60B

Cash Flow

In the last 12 months, operating cash flow was 5.50 billion and capital expenditures -951.13 million, giving a free cash flow of 4.54 billion.

Operating Cash Flow	5.50B
Capital Expenditures	-951.13M
Free Cash Flow	4.54B
FCF Per Share	n/a

Margins

Gross margin is 26.84%, with operating and profit margins of 4.56% and 2.83%.

Gross Margin	26.84%
Operating Margin	4.56%
Pretax Margin	3.73%
Profit Margin	2.83%
EBITDA Margin	4.96%
EBIT Margin	4.56%
FCF Margin	2.82%

Dividends & Yields

This stock pays an annual dividend of 6.10, which amounts to a dividend yield of 2.08%.

Dividend Per Share	6.10
Dividend Yield	2.08%
Dividend Growth (YoY)	6.00%
Years of Dividend Growth	6
Payout Ratio	28.40%
Buyback Yield	2.43%
Shareholder Yield	4.50%
Earnings Yield	7.74%
FCF Yield	7.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5